Here, Tregs suppress not only the production of interferon gamma (IFNγ) but also the expansion and activation-induced cell death of HCV-specific T cells resulting in reduced CD4+ T cell reactivity and mitigation of T cell-mediated liver disease (105–109). This evidence concerns the gene IFNG and liver disorder.